Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell. Founded by Robert Henkin in 2014, Cyrano Therapeutics is headquartered in Washington.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.